Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 2884 3732 3735 3791 3794
This examiner grants 46% of resolved cases
Karen E. Toth is an examiner in Tech Center 3700 and Art Unit 2884. She has a history with 767 resolved cases, providing a base of data for analysis. Her allowance rate is 46.4 percent, which indicates the proportion of applications that reach a grant. The median days to allowance is 1733, reflecting the pendency period for those seeking a patent. These figures are the primary metrics for her work in this art unit.
Interviews are a tool used with this examiner, as the data shows an interview lift of 25.8 percent. This suggests that direct discussion is associated with a change in the chances of success. Given the 1733-day median wait time, practitioners should consider the 25.8 percent lift when planning their strategy. With 767 cases resolved, this lift is a factor in navigating the 46.4 percent allowance rate. Direct engagement is a documented part of the prosecution history for Tech Center 3700.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19036792 | ESTIMATING METRICS FROM SENSORS OF A WEARABLE ARTICLE | Final Rejection | NIKE, Inc. |
| 18709392 | BIOPSY TOOL | Final Rejection | INTUITIVE SURGICAL OPERATIONS, INC. |
| 18948785 | SOFTWARE APPLICATIONS RESIDING ON HANDHELD ANALYTE DETERMINING DEVICES | Final Rejection | ABBOTT DIABETES CARE INC. |
| 17532755 | ANALYTE MONITORING DEVICES AND METHODS | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 18042074 | Physiological Data Collection Method and Apparatus, and Wearable Device | Non-Final OA | Huawei Technologies Co., Ltd. |
| 18219231 | SAFE VENTILATION IN THE PRESENCE OF RESPIRATORY EFFORT | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18749276 | BODY WEARABLE ANALYTE SENSOR SYSTEM WITH INFRARED TEMPERATURE SENSOR DEVICE | Non-Final OA | Roche Diabetes Care, Inc. |
| 18286693 | MONITORING PHYSIOLOGIC PARAMETERS IN HEALTH AND DISEASE USING LIDAR | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18547150 | METHOD FOR DIAGNOSING AND TREATING PARTIAL LIPODYSTROPHY | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18100061 | Biomarkers Predictive of Atopic Dermatitis | Final Rejection | Johnson & Johnson Consumer Inc. |
| 18634308 | METHOD AND APPARATUS FOR LEFT VENTRICULAR END DIASTOLIC PRESSURE MEASUREMENT | Non-Final OA | California Institute of Technology |
| 17996911 | SYSTEMS AND METHODS FOR ADMINISTERING A SMELL TEST FOR SARS CORONAVIRUSES AND COVID-19 | Non-Final OA | The General Hospital Corporation |
| 18169400 | SENSOR ATTACHMENT SYSTEM, RESPIRATORY GAS SENSOR, AND COMPATIBLE AIRWAY ADAPTOR | Final Rejection | NIHON KOHDEN CORPORATION |
| 18220565 | Location-Aided Glycemic Control | Non-Final OA | Dexcom, Inc. |
| 18731841 | DETERMINATION OF A USER’S GLYCATED HEMOGLOBIN LEVEL USING PULSE SPECTROSCOPY | Non-Final OA | Garmin International, Inc. |
| 17062666 | ELECTRONIC BLOOD PRESSURE METER AND HEART FAILURE DETECTOR | Non-Final OA | OMRON HEALTHCARE CO., LTD. |
| 16365263 | DEVICES AND METHODS FOR MONITORING OXYGENATION URING TREATMENT WITH DELIVERY OF NITRIC OXIDE | Non-Final OA | Mallinckrodt Pharmaceuticals Ireland Limited |
| 18385206 | BRAIN STIMULATION SIGNAL CONTROL METHOD, DEVICE AND SYSTEM | Final Rejection | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE |
| 18742987 | METHODS FOR DETECTING AND PREVENTING ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT | Non-Final OA | RAMOT AT TEL-AVIV UNIVERSITY LTD. |
| 18563707 | MONITORING OF UPPER LIMB MOVEMENTS TO DETECT STROKE | Final Rejection | The Trustees of the University of Pennsylvania |
| 17631447 | METHOD FOR MANAGING CALIBRATION INFORMATION IN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEM | Final Rejection | I-SENS, INC. |
| 17973738 | DEVICES, SYSTEMS, AND METHODS FOR DIAGNOSING TREATING AND MONITORING CHRONIC PELVIC PAIN | Non-Final OA | Baylor College of Medicine |
| 18628033 | DEVICES, SYSTEMS, AND METHODS FOR ASSESSING A VESSEL | Final Rejection | IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy